Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity.
暂无分享,去创建一个
G. Hart | R. Copeland | J. Bullen | Gerald W Hart | Ronald J Copeland | John W Bullen | Ronald J. Copeland | John W. Bullen
[1] M. Buse,et al. Identification of the Major Site of O-Linked β-N-Acetylglucosamine Modification in the C Terminus of Insulin Receptor Substrate-1 *S , 2006, Molecular & Cellular Proteomics.
[2] G. Hart,et al. Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol. , 1994, The Journal of biological chemistry.
[3] E. Meese,et al. Novel immunogenic antigen homologous to hyaluronidase in meningioma. , 1998, Human molecular genetics.
[4] R. Tjian,et al. Distinct regions of Sp1 modulate DNA binding and transcriptional activation. , 1988, Science.
[5] M. Buse,et al. Reduction of O-GlcNAc protein modification does not prevent insulin resistance in 3T3-L1 adipocytes. , 2007, American journal of physiology. Endocrinology and metabolism.
[6] M. Hoshijima,et al. Adenovirus-Mediated Overexpression of O-GlcNAcase Improves Contractile Function in the Diabetic Heart , 2005, Circulation research.
[7] R. Haltiwanger,et al. Modulation of O-LinkedN-Acetylglucosamine Levels on Nuclear and Cytoplasmic Proteins in Vivo Using the PeptideO-GlcNAc-β-N-acetylglucosaminidase InhibitorO-(2-Acetamido-2-deoxy-dglucopyranosylidene)amino-N-phenylcarbamate* , 1998, The Journal of Biological Chemistry.
[8] M. Carroll,et al. Characterisation of human N‐acetyl‐β‐hexosaminadase C , 1974 .
[9] Ming Tong,et al. Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.
[10] W. Prinz,et al. Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer , 2006, Proceedings of the National Academy of Sciences.
[11] G. Hart,et al. Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine:polypeptide beta-N-acetylglucosaminyltransferase. , 1992, The Journal of biological chemistry.
[12] G. Blatch,et al. The tetratricopeptide repeat: a structural motif mediating protein-protein interactions. , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.
[13] G. Hart,et al. O‐GlcNAc cycling: How a single sugar post‐translational modification is changing the Way We think about signaling networks , 2006, Journal of cellular biochemistry.
[14] W. Choi,et al. Glucosamine-induced insulin resistance in 3T3-L1 adipocytes. , 2000, American journal of physiology. Endocrinology and metabolism.
[15] K. Schey,et al. High glucose and insulin promote O-GlcNAc modification of proteins, including alpha-tubulin. , 2003, American journal of physiology. Endocrinology and metabolism.
[16] A. Goldfine,et al. The cellular fate of glucose and its relevance in type 2 diabetes. , 2004, Endocrine reviews.
[17] J. Hanover,et al. The Hexosamine Signaling Pathway: Deciphering the "O-GlcNAc Code" , 2005, Science's STKE.
[18] G. King,et al. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes , 2007, Nature Clinical Practice Endocrinology &Metabolism.
[19] G. Hart,et al. Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins , 2001, The Journal of Biological Chemistry.
[20] E. Gulve,et al. Development and comparison of two 3T3-L1 adipocyte models of insulin resistance: increased glucose flux vs glucosamine treatment. , 2000, Biochemical and biophysical research communications.
[21] Lance Wells,et al. Quantitative analysis of both protein expression and serine / threonine post‐translational modifications through stable isotope labeling with dithiothreitol , 2005, Proteomics.
[22] S. Withers,et al. NAG-thiazoline, An N-Acetyl-β-hexosaminidase Inhibitor That Implicates Acetamido Participation , 1996 .
[23] G. Hart,et al. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. , 2007, Nature.
[24] Wei Chen,et al. Role of the glucosamine pathway in fat-induced insulin resistance. , 1997, The Journal of clinical investigation.
[25] G. Hart,et al. O-GlcNAc Transferase Is in a Functional Complex with Protein Phosphatase 1 Catalytic Subunits* , 2004, Journal of Biological Chemistry.
[26] N. Raikhel,et al. Protein import into the nucleus: an integrated view. , 1995, Annual review of cell and developmental biology.
[27] T Szkudelski,et al. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. , 2001, Physiological research.
[28] J. Hanover,et al. Functional Expression of O-linked GlcNAc Transferase , 2000, The Journal of Biological Chemistry.
[29] R. Cole,et al. Alternative O-glycosylation/O-phosphorylation of the murine estrogen receptor beta. , 2000, Biochemistry.
[30] M. Buse. Hexosamines, insulin resistance, and the complications of diabetes: current status. , 2006, American journal of physiology. Endocrinology and metabolism.
[31] G. Hart,et al. Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins , 2002, The Journal of Biological Chemistry.
[32] Jianxin Xie,et al. Hepatic Glucose Sensing via the CREB Coactivator CRTC2 , 2008, Science.
[33] G. Hart,et al. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[34] J. Hanover,et al. Distinctive inhibition of O-GlcNAcase isoforms by an alpha-GlcNAc thiolsulfonate. , 2007, Journal of the American Chemical Society.
[35] G. Hart,et al. Dynamic Glycosylation of Nuclear and Cytosolic Proteins , 1997, The Journal of Biological Chemistry.
[36] R. Haltiwanger,et al. SV40 large T antigen is modified with O-linked N-acetylglucosamine but not with other forms of glycosylation. , 1998, Glycobiology.
[37] G. Hart,et al. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[38] B. Trigatti,et al. Glucosamine-induced endoplasmic reticulum dysfunction is associated with accelerated atherosclerosis in a hyperglycemic mouse model. , 2006, Diabetes.
[39] G. Hart,et al. Dynamic nuclear and cytoplasmic glycosylation: enzymes of O-GlcNAc cycling. , 2003, Biochemistry.
[40] K. Docherty,et al. Glucose Stimulates Translocation of the Homeodomain Transcription Factor PDX1 from the Cytoplasm to the Nucleus in Pancreatic β-Cells* , 1999, The Journal of Biological Chemistry.
[41] Q. Qian,et al. Glucose Mediates the Translocation of NeuroD1 by O-Linked Glycosylation* , 2007, Journal of Biological Chemistry.
[42] Gerald W. Hart,et al. Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins , 2007, Nature.
[43] James O. Wrabl,et al. Homology between O-linked GlcNAc transferases and proteins of the glycogen phosphorylase superfamily. , 2001, Journal of molecular biology.
[44] G. Hart,et al. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation/phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens. , 2002, The Journal of biological chemistry.
[45] N. Barzilai,et al. The Tissue Concentration of UDP-N-acetylglucosamine Modulates the Stimulatory Effect of Insulin on Skeletal Muscle Glucose Uptake* , 1997, The Journal of Biological Chemistry.
[46] J. Hanover,et al. Elevated O-linked N-acetylglucosamine metabolism in pancreatic beta-cells. , 1999, Archives of biochemistry and biophysics.
[47] Carolyn R Bertozzi,et al. A chemical approach for identifying O-GlcNAc-modified proteins in cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[48] J. Shabanowitz,et al. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[49] G. Wu,et al. Glutamine metabolism to glucosamine is necessary for glutamine inhibition of endothelial nitric oxide synthesis. , 2001, The Biochemical journal.
[50] R. Kornfeld. Studies on L-glutamine D-fructose 6-phosphate amidotransferase. I. Feedback inhibition by uridine diphosphate-N-acetylglucosamine. , 1967, The Journal of biological chemistry.
[51] Fengxue Zhang,et al. Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase. , 2002, Biochemical and biophysical research communications.
[52] E. Schleicher,et al. Palmitate-induced activation of the hexosamine pathway in human myotubes: increased expression of glutamine:fructose-6-phosphate aminotransferase. , 2003, Diabetes.
[53] S. Ficarro,et al. Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[54] A. Pandey,et al. Dynamic Interplay between O-Linked N-Acetylglucosaminylation and Glycogen Synthase Kinase-3-dependent Phosphorylation* , 2007, Molecular & Cellular Proteomics.
[55] S Marshall,et al. Coordinated regulation of glutamine:fructose-6-phosphate amidotransferase activity by insulin, glucose, and glutamine. Role of hexosamine biosynthesis in enzyme regulation. , 1991, The Journal of biological chemistry.
[56] Xiaoyong Yang,et al. Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development. , 2006, Glycobiology.
[57] B. Ueberheide,et al. The utility of ETD mass spectrometry in proteomic analysis. , 2006, Biochimica et biophysica acta.
[58] Linda C Hsieh-Wilson,et al. A chemoenzymatic approach toward the rapid and sensitive detection of O-GlcNAc posttranslational modifications. , 2003, Journal of the American Chemical Society.
[59] G. Parker,et al. Hyperglycemia and Inhibition of Glycogen Synthase in Streptozotocin-treated Mice , 2004, Journal of Biological Chemistry.
[60] D. Eick,et al. Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines. , 1994, Oncogene.
[61] S. Dimmeler,et al. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. , 2001, The Journal of clinical investigation.
[62] J. Hanover,et al. Distinctive inhibition of O-GlcNAcase isoforms by an α-GlcNAc thiolsulfonate , 2007 .
[63] J. Michalski,et al. Effect of okadaic acid on O-linked N-acetylglucosamine levels in a neuroblastoma cell line. , 1999, Biochimica et biophysica acta.
[64] Scott B Ficarro,et al. Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics. , 2007, Nature chemical biology.
[65] M. Jinek,et al. The superhelical TPR-repeat domain of O-linked GlcNAc transferase exhibits structural similarities to importin α , 2004, Nature Structural &Molecular Biology.
[66] G. Hart,et al. Dynamic interplay between O-GlcNAc and O-phosphate: the sweet side of protein regulation. , 2003, Current opinion in structural biology.
[67] G. Hart,et al. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats. , 2007, Glycobiology.
[68] G. Hart,et al. c-Myc Is Glycosylated at Threonine 58, a Known Phosphorylation Site and a Mutational Hot Spot in Lymphomas (*) , 1995, The Journal of Biological Chemistry.
[69] G. Hart,et al. Dynamic O-GlcNAcylation of the small heat shock protein alpha B-crystallin. , 1996, Biochemistry.
[70] P. Iyengar,et al. The Hyperglycemia-induced Inflammatory Response in Adipocytes , 2005, Journal of Biological Chemistry.
[71] G. Davies,et al. Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise. , 2007, Journal of the American Chemical Society.
[72] G. Hart,et al. Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. , 1984, The Journal of biological chemistry.
[73] A. Burnett,et al. Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[74] G. Hart,et al. Identification and Cloning of a Novel Family of Coiled-coil Domain Proteins That Interact with O-GlcNAc Transferase* , 2003, The Journal of Biological Chemistry.
[75] G. Hart,et al. Identification of O-GlcNAc sites on proteins. , 2006, Methods in enzymology.
[76] Margaret F. Gregor,et al. Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease Published, JLR Papers in Press, May 9, 2007. , 2007, Journal of Lipid Research.
[77] G. Hart,et al. Localization of the O-linked N-acetylglucosamine transferase in rat pancreas. , 1999, Diabetes.
[78] Jonathan C Trinidad,et al. O-Linked N-Acetylglucosamine Proteomics of Postsynaptic Density Preparations Using Lectin Weak Affinity Chromatography and Mass Spectrometry*S , 2006, Molecular & Cellular Proteomics.
[79] W. Yang,et al. Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability , 2006, Nature Cell Biology.
[80] D. McClain. Hexosamines as mediators of nutrient sensing and regulation in diabetes. , 2002, Journal of diabetes and its complications.
[81] Sun-Hee Kim,et al. o-GlcNAc transferase is activated by CaMKIV-dependent phosphorylation under potassium chloride-induced depolarization in NG-108-15 cells. , 2008, Cellular signalling.
[82] G. Hart,et al. Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins. Identification of a uridine diphospho-N-acetylglucosamine:peptide beta-N-acetylglucosaminyltransferase. , 1990, The Journal of biological chemistry.
[83] M. Quon,et al. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. , 2000, Circulation.
[84] M. Fukuda,et al. Diabetes and the Accompanying Hyperglycemia Impairs Cardiomyocyte Calcium Cycling through Increased Nuclear O-GlcNAcylation* , 2003, Journal of Biological Chemistry.
[85] T. Hunter,et al. The Protein Kinase Complement of the Human Genome , 2002, Science.
[86] L. Rossetti. Perspective: Hexosamines and nutrient sensing. , 2000, Endocrinology.
[87] A. Nemeth,et al. Clinical and molecular genetics of primary dystonias , 1998, Neurogenetics.
[88] I. G. Fantus,et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[89] D. McClain,et al. Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo. , 1998, Metabolism: clinical and experimental.
[90] Linda C Hsieh-Wilson,et al. Chemical approaches to understanding O-GlcNAc glycosylation in the brain. , 2008, Nature chemical biology.
[91] G. Hart,et al. Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells. , 2005, Endocrinology.
[92] J. Hanover,et al. A Caenorhabditis elegans model of insulin resistance: altered macronutrient storage and dauer formation in an OGT-1 knockout. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[93] S. Marshall,et al. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. , 1991, The Journal of biological chemistry.
[94] C. Kahn,et al. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. , 1999, Diabetes.
[95] R. Hresko,et al. Enhanced O-GlcNAc protein modification is associated with insulin resistance in GLUT1-overexpressing muscles. , 2002, American journal of physiology. Endocrinology and metabolism.
[96] R. Mirmira,et al. Transcription factors direct the development and function of pancreatic beta cells. , 2003, Trends in endocrinology and metabolism: TEM.
[97] G. Hart,et al. Regulation of a Cytosolic and Nuclear O-GlcNAc Transferase , 1999, The Journal of Biological Chemistry.
[98] J. Hanover,et al. O-Linked GlcNAc Transferase Is a Conserved Nucleocytoplasmic Protein Containing Tetratricopeptide Repeats* , 1997, The Journal of Biological Chemistry.
[99] Gerald W. Hart,et al. Glycosylation of Nucleocytoplasmic Proteins: Signal Transduction and O-GlcNAc , 2001, Science.
[100] Nathan L. Vanderford,et al. Glucose Induces MafA Expression in Pancreatic Beta Cell Lines via the Hexosamine Biosynthetic Pathway* , 2007, Journal of Biological Chemistry.
[101] W. Bremner,et al. Advances in male contraception. , 2008, Endocrine reviews.
[102] I. G. Fantus,et al. Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells. , 2000, Diabetes.
[103] G. Hart,et al. The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc. , 1986, The Journal of biological chemistry.
[104] J. Hanover,et al. Elevated O-LinkedN-Acetylglucosamine Metabolism in Pancreatic β-Cells , 1999 .
[105] R. Duggirala,et al. A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-D glucosaminidase is associated with type 2 diabetes in Mexican Americans. , 2005, Diabetes.
[106] Lance Wells,et al. Mapping Sites of O-GlcNAc Modification Using Affinity Tags for Serine and Threonine Post-translational Modifications* , 2002, Molecular & Cellular Proteomics.
[107] R. Davis,et al. Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[108] D. Görlich,et al. Nuclear protein import. , 1997, Current opinion in cell biology.
[109] M G McInnis,et al. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. , 2000, Science.
[110] G. Parker,et al. Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[111] S. Walker,et al. A strategy to discover inhibitors of O-linked glycosylation. , 2008, Journal of the American Chemical Society.
[112] R. Tjian,et al. O-glycosylation of eukaryotic transcription factors: Implications for mechanisms of transcriptional regulation , 1988, Cell.
[113] G. Sesti,et al. Insulin-Dependent Activation of Endothelial Nitric Oxide Synthase Is Impaired by O-Linked Glycosylation Modification of Signaling Proteins in Human Coronary Endothelial Cells , 2002, Circulation.
[114] M. Carroll,et al. Characterisation of human N-acetyl-beta-hexosaminidase C. , 1974, FEBS letters.
[115] G. Parker,et al. Insulin Resistance of Glycogen Synthase Mediated byO-Linked N-Acetylglucosamine* , 2003, The Journal of Biological Chemistry.
[116] P. Puigserver,et al. O-GlcNAc Regulates FoxO Activation in Response to Glucose* , 2008, Journal of Biological Chemistry.
[117] J. Miyazaki,et al. The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 beta-cells. , 2003, Archives of biochemistry and biophysics.
[118] A. Paterson,et al. Streptozotocin, an O-GlcNAcase inhibitor, blunts insulin and growth hormone secretion , 2002, Molecular and Cellular Endocrinology.
[119] A. Vasella,et al. Inhibition of O‐GlcNAcase by a gluco‐Configured Nagstatin and a PUGNAc—Imidazole Hybrid Inhibitor. , 2007 .
[120] H. Heimberg,et al. Glucosamine-induced Insulin Resistance in 3T3-L1 Adipocytes Is Caused by Depletion of Intracellular ATP* , 1998, The Journal of Biological Chemistry.
[121] K. Schey,et al. High glucose and insulin promote O-GlcNAc modification of proteins, including α-tubulin , 2003 .
[122] R. Mirmira,et al. Transcription factors direct the development and function of pancreatic β cells , 2003, Trends in Endocrinology & Metabolism.
[123] R. Marchase,et al. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc. , 2007, American journal of physiology. Cell physiology.
[124] G. Hart,et al. Erratum: Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 (PAI-1) gene expression and Sp1 transcriptional activity in glomerular mesangial cells (Endocrinology (2006) 147 (222-231)) , 2006 .
[125] W. V. So,et al. Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance , 2008, Nature.
[126] G. Hart,et al. O-GlcNAc modification in diabetes and Alzheimer's disease. , 2007, Molecular bioSystems.